CNTX
Context Therapeutics Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:41 PM EST
0.16USD-4.971%(-0.01)1,244,151
Pre-marketNov 18, 2026 8:53:30 AM EST
0.1764USD+3.158%(+0.0054)
After-hoursNov 18, 2026 4:09:30 PM EST
0.1631USD+0.369%(+0.0006)
Loading…
Loading…
15.11M
Healthcare
Biotechnology
HQ
Philadelphia, PA, USA
Previous Close
$0.17
Beta
0.53
52-Week High
$3.62 2026-03-16
52-Week Low
$0.15 2026-11-17
SMA 50
$0.28
SMA 200
$1.35
Avg. Vol 10D
2.00M
Avg. Vol 30D
1.42M
Avg. Vol 90D
1.56M
Relative Vol
0.88
91.88M
63.73M
69.37%
4,695,883
7.37%
3.68
39%/61%
65.27%
49.41%
0.5500%
1,600,000
4,540
3,494
4,540
-43.9M
-0.46
-34.0M
-84.26
CNTX Profile
context therapeutics is dedicated to discovering, acquiring, and developing novel compounds to treat hormone responsive cancers. our lead program is apristor (onapristone xr), an investigational drug for progesterone receptor positive (pr+) breast cancer. up to 70% of breast cancers express progesterone receptor (pr). if your cancer is pr+, apristor could be an option for you.
CNTX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.22 | 2026-11-11 | -23.88% | -0.922 |
| 1M | 0.24 | 2026-10-19 | -31.00% | 2.127 |
| 3M | 0.50 | 2026-08-18 | -66.87% | 1.632 |
| 6M | 2.15 | 2026-05-18 | -92.35% | 0.801 |
| 1Y | 1.08 | 2025-11-18 | -84.77% | 0.532 |
| 2Y | 1.68 | 2024-11-18 | -90.21% | — |
| 5Y | 4.45 | 2021-11-18 | -96.30% | 0.894 |
CNTX Stock Summary
Context Therapeutics Inc. Common Stock (NASDAQ:CNTX) stock price today is $0.16, and today's volume is 1,244,151. CNTX is down 3.801% today. The 30 day average volume is 1.42M. CNTX market cap is $15.11M with 91.88M shares outstanding.